Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma

PURPOSE: Therapeutic advances for diffuse large B-cell lymphoma (DLBCL) have led to an increasing number of survivors. Both DLBCL and its treatments perturb the immune system, yet little is known about immune health during extended survivorship. METHODS: In this retrospective cohort study, we compar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Shree, Tanaya, Li, Qian, Glaser, Sally L., Brunson, Ann, Maecker, Holden T., Haile, Robert W., Levy, Ronald, Keegan, Theresa H. M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2020
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238489/
https://ncbi.nlm.nih.gov/pubmed/32083991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01937
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars